Overview
An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of leucine. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels.
Indication
The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Baxter Healthcare Corporation | 0338-0184 | INTRAVENOUS | 480 mg in 100 mL | 4/13/2021 | |
| Baxter Healthcare Company | 0338-0210 | INTRAVENOUS | 480 mg in 100 mL | 9/21/2020 | |
| Baxter Healthcare Corporation | 0338-0210 | INTRAVENOUS | 480 mg in 100 mL | 9/21/2020 | |
| Baxter Healthcare Corporation | 0338-1089 | INTRAVENOUS | 255 mg in 100 mL | 4/13/2021 | |
| Baxter Healthcare Corporation | 0338-1099 | INTRAVENOUS | 300 mg in 100 mL | 4/13/2021 | |
| ICU Medical Inc. | 0990-7171 | INTRAVENOUS | 990 mg in 100 mL | 5/4/2022 | |
| Baxter Healthcare Corporation | 0338-0194 | INTRAVENOUS | 480 mg in 100 mL | 4/13/2021 | |
| Baxter Healthcare Company | 0338-1147 | INTRAVENOUS | 300 mg in 100 mL | 9/21/2020 | |
| Baxter Healthcare Corporation | 0338-1147 | INTRAVENOUS | 300 mg in 100 mL | 9/21/2020 | |
| Baxter Healthcare Company | 0338-1142 | INTRAVENOUS | 165 mg in 100 mL | 9/21/2020 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| AMINOVEN SOLUTION FOR INFUSION 5% | SIN11682P | INJECTION | 2.500 g/1000 ml | 9/25/2001 | |
| NUTRIFLEX® OMEGA SPECIAL B. BRAUN EMULSION FOR INFUSION | SIN16734P | INJECTION, EMULSION | 3.284g/1000ml | 3/7/2023 | |
| NUTRINEAL PD4 WITH 1.1% AMINO ACID SOLUTION | SIN09353P | SOLUTION, STERILE | 0.85 g/l | 5/27/1997 | |
| SMOFKABIVEN EXTRA NITROGEN EMULSION FOR INFUSION | SIN16135P | INJECTION, EMULSION | 3.3g/1000ml | 3/24/2021 | |
| OLICLINOMEL N4-550 E EMULSION FOR INFUSION | SIN12542P | EMULSION | 1.32 g/l | 5/6/2004 | |
| SmofKabiven Emulsion for Infusion | SIN14286P | INJECTION, EMULSION | 5.0g /1000ml | 1/8/2013 | |
| SmofKabiven Electrolyte Free Emulsion for Infusion | SIN14292P | INJECTION, EMULSION | 5.0g /1000ml | 1/16/2013 | |
| OLICLINOMEL N7-1000 E EMULSION FOR INFUSION | SIN12539P | EMULSION | 2.40 g/l | 5/6/2004 | |
| NUTRIFLEX® OMEGA PLUS EMULSION FOR INFUSION | SIN15468P | INJECTION, EMULSION | 2.256g/1000ml | 4/23/2018 | |
| PERIOLIMEL N4E Emulsion for Infusion | SIN16888P | EMULSION | 1.26g/L | 10/20/2023 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| LA-FLAMING INJ. | N/A | N/A | N/A | 1/28/2010 | |
| VAMINOLACT I.V. SOLUTION | N/A | N/A | N/A | 10/14/1992 | |
| OLIMEL N9E EMULSION FOR INFUSION | N/A | N/A | N/A | 10/24/2013 | |
| NUTRIFLEX OMEGA SPECIAL EMULSION FOR INFUSION | N/A | N/A | N/A | 1/11/2012 | |
| SMOFKABIVEN EMULSION FOR INFUSION | N/A | N/A | N/A | 5/26/2011 | |
| PAN-AMIN G SOLUTION FOR INFUSION 500ML | N/A | otsuka pharmaceutical (h.k.) limited | N/A | N/A | 4/5/2012 |
| PAN-AMIN G INJ | N/A | N/A | N/A | 5/17/1979 | |
| NUTRIFLEX OMEGA PLUS EMULSION FOR INFUSION | N/A | N/A | N/A | 1/11/2012 | |
| AMINOGEN-S SOLUTION FOR INFUSION | N/A | wings pharmaceutical ltd | N/A | N/A | 8/15/2013 |
| LIVACT GRANULES | N/A | N/A | N/A | 6/6/2014 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| SYNTHAMIN 17 Amino acid 10% with Electrolytes and Glucose 25% 1000mL injection AHB6350 | 19609 | Medicine | A | 9/30/1991 | |
| AMINOVEN amino acid 10% solution for infusion 500 mL bottle | 117659 | Medicine | A | 10/22/2007 | |
| SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1970 mL | 180546 | Medicine | A | 1/9/2012 | |
| OLICLINOMEL N4-550 E 1000 mL IV emulsion for infusion with electrolytes bag | 136599 | Medicine | A | 9/4/2007 | |
| OLICLINOMEL N4-550 E 2500 mL IV emulsion for infusion with electrolytes bag | 141396 | Medicine | A | 9/4/2007 | |
| OLIMEL N5-860E Emulsion for intravenous infusion | 197417 | Medicine | A | 8/9/2013 | |
| Olimel N12-640 emulsion for intravenous infusion bag. | 303755 | Medicine | A | 7/1/2019 | |
| MUSASHI SLEEP RECOVERY | 308710 | Medicine | A | 8/28/2018 | |
| SMOFKABIVEN LOW OSMO amino acids 2.5%, electrolytes 0.4%, lipids 3.5% & glucose 6.8% emulsion for intravenous infusion 2500 mL biofine bag | 329619 | Medicine | A | 8/27/2020 | |
| MOUTH ULCER | 343446 | Medicine | A | 9/14/2020 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE | baxter corporation clintec nutrition division | N/A | Solution - Intravenous | 255 MG / 100 ML | 12/31/1996 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTRLYTES IN 10% DEXTROSE | baxter corporation clintec nutrition division | N/A | Solution - Intravenous | 255 MG / 100 ML | 12/31/1996 |
| 2.75%TRAVASOL AMINO ACID INJ.W.ELEC.W.5%DEX. | clintec nutrition company | 02143240 | Liquid - Intravenous | 165 MG / 100 ML | 12/31/1996 |
| 4.25%TRAVASOL AMINO ACID INJ.W.ELECW.5%DEX. | clintec nutrition company | 02143224 | Liquid - Intravenous | 255 MG / 100 ML | 12/31/1996 |
| 5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 25% DEXTROSE | baxter corporation clintec nutrition division | 02142244 | Solution - Intravenous | 300 MG / 100 ML | 12/31/1996 |
| 2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE CLINIMIX | baxter corporation clintec nutrition division | 02013975 | Solution - Intravenous | 120 MG / 100 ML | 12/31/1993 |
| CLINIMIX E | baxter corporation | 02013967 | Solution - Intravenous | 240 MG / 100 ML | 12/31/1993 |
| 5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE | baxter corporation clintec nutrition division | 02142252 | Solution - Intravenous | 300 MG / 100 ML | 12/31/1996 |
| 5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE | baxter corporation clintec nutrition division | 02142368 | Solution - Intravenous | 300 MG / 100 ML | 12/31/1996 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 25% DEXTROSE | baxter corporation clintec nutrition division | 02142295 | Solution - Intravenous | 255 MG / 100 ML | 12/31/1996 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| NEPHROTECT SOLUCION PARA PERFUSION | 67038 | SOLUCIÓN PARA PERFUSIÓN | Uso Hospitalario | Commercialized | |
| SMOFKABIVEN PERIFERICO EMULSION PARA PERFUSION | Fresenius Kabi España, S.A.U. | 70513 | EMULSIÓN PARA PERFUSIÓN | Uso Hospitalario | Commercialized |
| PEDIAVEN G20 SOLUCION PARA PERFUSION | Fresenius Kabi España, S.A.U. | 78951 | SOLUCIÓN PARA PERFUSIÓN | Uso Hospitalario | Not Commercialized |
| AMINOVEN INFANT 10% SOLUCION PARA PERFUSION | Fresenius Kabi España, S.A.U. | 59628 | SOLUCIÓN PARA PERFUSIÓN | Uso Hospitalario | Commercialized |
| SMOFKABIVEN EXTRA NITROGEN EMULSION PARA PERFUSION | Fresenius Kabi España, S.A.U. | 82509 | EMULSIÓN PARA PERFUSIÓN | Uso Hospitalario | Commercialized |
| SMOFKABIVEN SIN ELECTROLITOS CENTRAL EMULSION PARA PERFUSION | Fresenius Kabi España, S.A.U. | 70892 | EMULSIÓN PARA PERFUSIÓN | Uso Hospitalario | Commercialized |
| LIPOFLEX SPECIAL SIN ELECTROLITOS EMULSION PARA PERFUSION EFG | 82266 | EMULSIÓN PARA PERFUSIÓN | Uso Hospitalario | Commercialized | |
| OMEGAFLEX ESPECIAL EMULSION PARA PERFUSION | 82104 | EMULSIÓN PARA PERFUSIÓN | Uso Hospitalario | Commercialized | |
| SYNTHAMIN 17 REFORMULADO SOLUCION PARA PERFUSION | Baxter S.L. | 58196 | SOLUCIÓN PARA PERFUSIÓN | Uso Hospitalario | Commercialized |
| AMINOPLASMAL PAED 10% SOLUCION PARA PERFUSION | 78871 | SOLUCIÓN PARA PERFUSIÓN | Uso Hospitalario | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.